<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: Since Helicobacter pylori (Hp) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> provokes intestinal and <z:mp ids='MP_0005213'>gastric metaplasia</z:mp>, the question arises whether the specialized <z:mpath ids='MPATH_160'>metaplasia</z:mpath> (Barrett's mucosa (BM)) and <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0002038'>carcinoma</z:mp> in Barrett's epithelium seen in <z:e sem="disease" ids="C0017168" disease_type="Disease or Syndrome" abbrv="GERD">gastro-oesophageal reflux disease</z:e> (GORD) might not also be correlated with Hp <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e>, or whether the latter offers protection against <z:e sem="disease" ids="C0004763" disease_type="Disease or Syndrome" abbrv="CELLO">Barrett's oesophagus</z:e> and Barrett's <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS: Gastric and oesophageal biopsies obtained from a total of 2,201 patients were analysed retrospectively </plain></SENT>
<SENT sid="2" pm="."><plain>297 of these patients had GORD (age 53.5 +/- 13.4 years; m:f ratio 2.1:1), 1,192 patients had BM (age 62.8 +/- 14.6 years; m:f 2.3:1) with or without <z:hpo ids='HP_0002664'>neoplasia</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>1,054 of these patients were diagnosed as having BM alone, 138 patients having BM <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (high-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> or <z:mp ids='MP_0009308'>adenocarcinoma</z:mp>) </plain></SENT>
<SENT sid="4" pm="."><plain>Patients with BM and low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> were excluded from this study because of the uncertainty in differentiating low-grade <z:mpath ids='MPATH_589'>dysplasia</z:mpath> from regenerative epithelium </plain></SENT>
<SENT sid="5" pm="."><plain>A total of 712 patients with non-<z:mpath ids='MPATH_579'>ulcer</z:mpath> <z:e sem="disease" ids="C0013395" disease_type="Disease or Syndrome" abbrv="">dyspepsia</z:e> (NUD; average age 40.0 +/- 16.1 years; m:f 0.3:1) served as a control group </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: The percentage of Hp <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> did not differ between patients with GORD with (53.3%)/without BM (51.4%) and <z:hpo ids='HP_0002664'>neoplasia</z:hpo> (47.8%), but is statistically significantly lower than in patients with NUD (65.7%) </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: Our analysis shows that patients with GORD and Hp <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> have no increased risk for the development of BM or <z:hpo ids='HP_0002664'>neoplasia</z:hpo> in BM </plain></SENT>
<SENT sid="8" pm="."><plain>Since Hp <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is significantly less frequent in GORD than in NUD patients, a protective effect of the Hp <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> is a possibility worth discussing </plain></SENT>
</text></document>